StockDrifts LogoStockDrifts

Dongbang Medical 240550

Company
동방메디컬Dongbang Medical
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2026-01-27

Dongbang Medical (240550) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Dongbang Medical is dated 2025-02-13; the most recent is 2026-01-27. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-01-27BUYPROGRAM
오세진
Sejin Oh
moving15.0K₩7,720+1.3%₩116M ($80K)
2026-01-27BUYPROGRAM
최낙이
Choi Nak-i
Managing Director27.7K₩7,720+1.3%₩214M ($148K)
2026-01-27BUYPROGRAM
김훈석
Hoonseok Kim
moving15.0K₩7,720+1.3%₩116M ($80K)
2026-01-27BUYPROGRAM
이창훈
Changhoon Lee
moving28.0K₩7,720+1.3%₩216M ($150K)
2026-01-27BUYPROGRAM
이선우
Seonwoo Lee
moving28.0K₩7,720+1.3%₩216M ($150K)
2026-01-27BUYPROGRAM
곽동열
Kwak Dong-yeol
moving10.0K₩7,720+1.3%₩77M ($54K)
2025-08-18BUY주식매수청구권 행사
최낙이
Choi Nak-i
Managing Director22.3K₩10,860-28.0%₩242M ($168K)
2025-04-23BUY주식매수선택권
신현호
Hyunho Shin
moving15.0K₩10,870-28.1%₩163M ($113K)
2025-04-23BUY주식매수청구권 행사
김영익
Youngik Kim
moving10.0K₩10,870-28.1%₩109M ($75K)
2025-02-13BUY신규상장
김근식
Kim Geun-sik
CEO10.0M₩9,680-19.2%₩96.7B ($67.2M)

Frequently asked questions

Who has been buying Dongbang Medical stock?
0 distinct insiders have filed 0 disclosed insider purchases in Dongbang Medical (240550), most recently on 2026-01-27. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Dongbang Medical have?
Dongbang Medical has 0 buy-side and 0 sell-side disclosures on record, spanning 2025-02-13 to 2026-01-27.
Where does StockDrifts get Dongbang Medical insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Dongbang Medical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.